Pro-Dex, Inc. (NASDAQ:PDEX - Get Free Report)'s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $45.79 and traded as high as $48.64. Pro-Dex shares last traded at $45.71, with a volume of 57,239 shares trading hands.
Analysts Set New Price Targets
A number of equities research analysts have recently commented on the stock. Wall Street Zen raised shares of Pro-Dex from a "hold" rating to a "buy" rating in a report on Tuesday, May 13th. Ascendiant Capital Markets upped their target price on shares of Pro-Dex from $54.00 to $56.00 and gave the company a "buy" rating in a report on Tuesday, May 27th.
Get Our Latest Report on PDEX
Pro-Dex Trading Up 2.6%
The company has a debt-to-equity ratio of 0.28, a current ratio of 2.73 and a quick ratio of 1.45. The business's 50 day moving average price is $45.15 and its 200-day moving average price is $45.84. The firm has a market capitalization of $155.67 million, a price-to-earnings ratio of 17.05 and a beta of 0.19.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in the company. Police & Firemen s Retirement System of New Jersey purchased a new position in Pro-Dex in the second quarter valued at about $28,000. Cubist Systematic Strategies LLC purchased a new position in Pro-Dex in the first quarter valued at about $170,000. Morgan Dempsey Capital Management LLC purchased a new position in Pro-Dex in the second quarter valued at about $179,000. Trexquant Investment LP purchased a new position in Pro-Dex in the fourth quarter valued at about $252,000. Finally, Arrowstreet Capital Limited Partnership purchased a new position in Pro-Dex in the fourth quarter valued at about $255,000. 15.28% of the stock is currently owned by institutional investors and hedge funds.
About Pro-Dex
(
Get Free Report)
Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
Further Reading
Before you consider Pro-Dex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pro-Dex wasn't on the list.
While Pro-Dex currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.